Live feed08:00:00·60dPRReleasevia QuantisnowEnlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee OsteoarthritisByQuantisnow·Wall Street's wire, on your screen.ENLV· Enlivex Ltd.Health Care
